Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for Windows
(Osteoporosis)
85,612 results
  • Microbial production of vitamin K2: current status and future prospects. [Review]
    Biotechnol Adv 2019; :107453Ren L, Peng C, … Huang H
  • Vitamin K2, also called menaquinone, is an essential lipid-soluble vitamin that plays a critical role in blood clotting and prevention of osteoporosis. It has become a focus of research in recent years and has been widely used in the food and pharmaceutical industries. This review will briefly introduce the functions and applications of vitamin K2 first, after which the biosynthesis pathways and …
  • Reply to Letter to the Editor (HEP-19-1638). [Letter]
    Hepatology 2019Arase Y, Kagawa T
  • Osteodystrophy is a worrisome complication in chronic liver diseases (CLD), especially in autoimmune liver diseases such as primary biliary cholangitis and autoimmune hepatitis accompanying vitamin D malabsorption and use of corticosteroid. As physical activity is closely associated with bone health (2) , physical inactivity in CLD is likely to worsen bone metabolism. We think that regular exerci…
  • Teriparatide treatment increases Hounsfield units in the lumbar spine out of proportion to DEXA changes. [Journal Article]
    J Neurosurg Spine 2019; :1-6Mikula AL, Puffer RC, … Elder BD
  • CONCLUSIONS: Teriparatide treatment increased both HU and BMD on DEXA in the lumbar spine, without a change in femoral BMD. The 22% improvement in HU surpassed the 9% improvement determined with DEXA. These results support some surgeons' subjective sense that intraoperative bone quality following teriparatide treatment is better than indicated by DEXA results. To the authors' knowledge, this is the first study demonstrating an increase in HU with teriparatide treatment.
New Search Next